Daily BriefsMost Read

Most Read: Zijin Gold, Makino Milling Machine Co, Tsuruha Holdings, Almonty Industries, Applied Materials, Toyota Industries, Medical Data Vision, Planet Labs, Pop Mart and more

In today’s briefing:

  • Gold Miners ETF (GDX US) Dec Rebalance: 5 Adds and US$8.8bn Trade; Zijin Gold Added
  • Makino Milling Machine (6135 JP): Progress Update While Mixed, Should Calm Nerves
  • [Japan Partial Tender] AEON (8267) Tender for TSURUHA (3391) Trading Rich
  • MV Global Rare Earth/​​​​​Strategic Metals Index Rebalance: 3 Adds and Other Changes; US$550m Trade
  • MV US Listed Semiconductor 25 Index Rebalance: Capping Leads to US$5.5bn Trade
  • Merger Arb Mondays (15 Dec) – Toyota Ind, Makino, Raksul, Pacific Ind, Jinke, Meilan Airport, NSR
  • Asia-Pac M&A Weekly Wrap: Toyota Inds, Predictive Discovery, Jinke Smart Services, Meilan Airport
  • [Japan M&A?] Nikkei Reports Nippon Life to Buy Medical Data Vision (3902) For ~¥60bn
  • MV Global Defense Industry Index Rebalance: 4 Adds; 5.8% Turnover; US$850m Trade
  • 2026 High Conviction: Sell Pop Mart Intl (9992 HK)


Gold Miners ETF (GDX US) Dec Rebalance: 5 Adds and US$8.8bn Trade; Zijin Gold Added

By Brian Freitas

  • There are 5 additions for the VanEck Gold Miners ETF/USA (GDX US) in December. Zijin Gold (2259 HK) is a surprise add (as are some of the others).
  • Estimated one-way turnover is 15.2% and that leads to a round-trip trade of US$8.8bn. There are many stocks with multiple days of ADV to trade from passive trackers.
  • The MarketVector Global Gold Miners Index has just passed its earlier highs, but a lot of the adds have broken out and are trading much higher than their prior highs.

Makino Milling Machine (6135 JP): Progress Update While Mixed, Should Calm Nerves

By Arun George

  • On Friday, after market close, Makino Milling Machine Co (6135 JP) finally issued a progress update on the MBK preconditional tender offer. The update, while mixed, should calm nerves. 
  • The positive read-across is a pathway to regulatory approvals, the Homeplus saga has not derailed the offer, and the likely breach of the long-stop date is not a termination event.
  • The negative read-across is the lack of a revised tender start timeline, an unexplained delay in securing most regulatory approvals and ongoing uncertainty on the long-stop date.

[Japan Partial Tender] AEON (8267) Tender for TSURUHA (3391) Trading Rich

By Travis Lundy


MV Global Rare Earth/​​​​​Strategic Metals Index Rebalance: 3 Adds and Other Changes; US$550m Trade

By Brian Freitas


MV US Listed Semiconductor 25 Index Rebalance: Capping Leads to US$5.5bn Trade

By Brian Freitas



Asia-Pac M&A Weekly Wrap: Toyota Inds, Predictive Discovery, Jinke Smart Services, Meilan Airport

By David Blennerhassett


[Japan M&A?] Nikkei Reports Nippon Life to Buy Medical Data Vision (3902) For ~¥60bn

By Travis Lundy

  • Medical Data Vision (3902 JP) was IPOed in 2014. MitCorp sold. Others sold. Fujifilm and Medipal stayed in. The stock ran up. SBI bought from Fujifilm in Nov2020 at ¥2355.
  • The stock fell, SBI bought more in 2021-2022. Then it fell more in 2023 and SBI bought more, then fell more in 2024 and SBI bought more. 
  • The Nikkei reports today that Nippon Life will announce a TOB on 15 December with a max price of ¥60bn (242% premium), which coincidentally would bring SBI close to breakeven.

MV Global Defense Industry Index Rebalance: 4 Adds; 5.8% Turnover; US$850m Trade

By Brian Freitas

  • BigBear.ai Holdings, NextVision Stabilized Systems, Ondas Holdings Inc and Planet Labs will be added to the MarketVector Global Defense Industry Index at the close on 19 December.
  • The 4 adds, float changes and capping changes will result in an estimated one-way turnover of 5.8% resulting in a round-trip trade of US$846m.
  • The adds have all run up over the last year and the passive buying could give the stocks another leg up in the short-term.

2026 High Conviction: Sell Pop Mart Intl (9992 HK)

By Ke Yan, CFA, FRM

  • Peak IP momentum risk: Labubu (~23% of revenue) shows fading hype, with resale prices and ex-China search interest normalizing, raising risk of faster-than-expected growth deceleration in 2026.
  • IP concentration and gap: No other IP has demonstrated Labubu-like scaling, increasing risk of an IP digestion period. Overseas expansion matures and supply normalization caps incremental demand.
  • Valuation/Expectations mismatch: At 14x 2026E P/E, valuation assumes durable IP growth; TP at HKD 100 to 105 with downgrade risk in 2H26.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars